Assignee
ACHILLION PHARMACEUTICALS INC
US·88 granted patents·28 pending applications·1,348 citations·filing 2002–2024
Top patents by PatentIndex Score
116 records- 0199US10822352B2Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Nov 3, 2020·20 cites·17 claims
- 0299US10550140B2Ether compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Feb 4, 2020·27 cites·20 claims
- 0399US10301336B2Phosphonate compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted May 28, 2019·27 cites·20 claims
- 0499US10287301B2Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted May 14, 2019·28 cites·18 claims
- 0599US10189869B2Amino compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Jan 29, 2019·27 cites·36 claims
- 0699US10138225B2Amide compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2016·Granted Nov 27, 2018·33 cites·31 claims
- 0799US10106563B2Ether compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Oct 23, 2018·30 cites·20 claims
- 0899US10100072B2Phosphonate compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Oct 16, 2018·27 cites·53 claims
- 0999US10092547B2Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero- heteraphanes and metallocenes useful for treating HCV infectionsACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Oct 9, 2018·19 cites·14 claims
- 1099US10081645B2Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Sep 25, 2018·27 cites·40 claims
- 1199US10011612B2Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2016·Granted Jul 3, 2018·30 cites·3 claims
- 1299US10005802B2Amide compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2016·Granted Jun 26, 2018·27 cites·38 claims
- 1399US10000516B2Phosphonate compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2016·Granted Jun 19, 2018·28 cites·28 claims
- 1499US9828396B2Alkyne compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Nov 28, 2017·30 cites·40 claims
- 1599US9796741B2Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Oct 24, 2017·37 cites·50 claims
- 1699US9758537B2Compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Sep 12, 2017·27 cites·39 claims
- 1799US9732103B2Carbamate, ester, and ketone compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Aug 15, 2017·32 cites·29 claims
- 1899US9732104B2Ether compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Aug 15, 2017·30 cites·68 claims
- 1999US9695205B2Amide compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Jul 4, 2017·32 cites·56 claims
- 2099US9663543B2Phosphonate compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted May 30, 2017·32 cites·49 claims
- 2199US9643986B2Factor D inhibitors useful for treating inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted May 9, 2017·30 cites·24 claims
- 2299US9598446B2Amino compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2015·Granted Mar 21, 2017·33 cites·7 claims
- 2398US11708351B2Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2021·Granted Jul 25, 2023·8 cites·17 claims
- 2498US11407738B2Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2020·Granted Aug 9, 2022·16 cites·12 claims
- 2598US11084800B2Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Aug 10, 2021·18 cites·11 claims
- 2698US10919884B2Amide compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Feb 16, 2021·20 cites·12 claims
- 2798US10906887B2Amino compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Feb 2, 2021·20 cites·12 claims
- 2898US10689409B2Amino compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Jun 23, 2020·9 cites·23 claims
- 2998US10662175B2Aryl, heteroaryl, and heterocyclic compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted May 26, 2020·20 cites·20 claims
- 3098US10464956B2Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Nov 5, 2019·21 cites·24 claims
- 3198US10428095B2Compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Oct 1, 2019·21 cites·2 claims
- 3298US10428094B2Amide compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Oct 1, 2019·21 cites·40 claims
- 3398US10370394B2Carbamate, ester, and ketone compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Aug 6, 2019·23 cites·35 claims
- 3498US10253053B2Aryl, heteroaryl, and heterocyclic compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Apr 9, 2019·22 cites·20 claims
- 3598US10087203B2Compounds for treatment of complement mediated disordersACHILLION PHARMACEUTICALS INC·Filed 2017·Granted Oct 2, 2018·25 cites·21 claims
- 3697US12006307B2Pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2022·Granted Jun 11, 2024·3 cites·7 claims
- 3797US11447465B2Pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Sep 20, 2022·16 cites·8 claims
- 3897US11053253B2Macrocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2019·Granted Jul 6, 2021·16 cites·9 claims
- 3997US11001600B2Disubstituted compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted May 11, 2021·16 cites·9 claims
- 4097US10807952B2Compounds for treatment of immune inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted Oct 20, 2020·20 cites·13 claims
- 4197US10660876B2Amino compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2018·Granted May 26, 2020·20 cites·14 claims
- 4297US7906619B24-amino-4-oxobutanoyl peptides as inhibitors of viral replicationACHILLION PHARMACEUTICALS INC·Filed 2007·Granted Mar 15, 2011·51 cites·28 claims
- 4396US12162860B2Aryl, heteroaryl, and heterocyclic pharmaceutical compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2023·Granted Dec 10, 2024·2 cites·20 claims
- 4496US11718626B2Macrocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2021·Granted Aug 8, 2023·3 cites·21 claims
- 4596US10092584B2Compounds for the treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2016·Granted Oct 9, 2018·28 cites·41 claims
- 4696US9273082B2Substituted aliphanes, cyclophanes, heteraphanes, heterophanes, hetero-heteraphanes and metallocenes useful for treating HCV infectionsACHILLION PHARMACEUTICALS INC·Filed 2014·Granted Mar 1, 2016·14 cites·17 claims
- 4795US12139497B2Aryl, heteroaryl, and heterocyclic compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2023·Granted Nov 12, 2024·1 cites·20 claims
- 4895US11649229B2Amide compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2020·Granted May 16, 2023·3 cites·20 claims
- 4995US11649223B2Amino compounds for treatment of immune and inflammatory disordersACHILLION PHARMACEUTICALS INC·Filed 2020·Granted May 16, 2023·3 cites·20 claims
- 5095US10385097B2Ether compounds for treatment of medical disordersACHILLION PHARMACEUTICALS INC·Filed 2016·Granted Aug 20, 2019·23 cites·27 claims
Showing the top 50 of 116 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →